(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EUROZYTO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

EUROZYTO

ST13

US500000088022973

Class

1, 5

Filing

88022973

Registration

5720223

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

08/09/2025

Classification

Registered

Trademark type

Word

Nice classes

1, 5

Filing date

07/02/2018

Registration date

04/09/2019

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/08/2025

Last transaction

08/09/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

16

Owner location

Königstein, DE

Examiner

HETZEL, DANNEAN

Current location

Historical data usage

Holders and representatives

Holders

Eurozyto GmbH

Representatives

Rebecca Liebowitz VENABLE LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals used in industryin particular for manufacturing pharmaceutical preparations and medicines

Class 5

pharmaceutical preparations and medicinesfor parenteral nutrition and intravenous parenteral nutrition; Pharmaceuticalscancer treatment drugs and cancer treatment drugs in the form of infusion solutions; Pharmaceutical preparations for the treatment of orphan diseasespharmaceutical preparations in the form of infusion solutions for the treatment of orphan diseases

Publications

History of USPTO decisions and trademark events.

20 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/08/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/08/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/08/2025

E815

TEAS SECTION 8 & 15 RECEIVED

04/04/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/09/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/22/2019

PUBO

PUBLISHED FOR OPPOSITION

01/22/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/02/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/14/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/14/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/14/2018

ALIE

ASSIGNED TO LIE

12/12/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/06/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/31/2018

GNRT

NON-FINAL ACTION E-MAILED

10/31/2018

CNRT

NON-FINAL ACTION WRITTEN

10/31/2018

DOCK

ASSIGNED TO EXAMINER

10/23/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/07/2018

NWAP

NEW APPLICATION ENTERED

07/05/2018

Continuous trademark protection

Get notified about every new filing that threatens EUROZYTO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.